Results 191 to 200 of about 38,934 (294)

Diabetic ketoacidosis

, 2016
Canavan, R., Price, A. M.
core  

Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses

Clinical and Translational Science, Volume 19, Issue 6, June 2026.
ABSTRACT Sodium glucose cotransporter‐2 (SGLT2) inhibitors are a class of antidiabetics with benefits including HbA1c‐lowering, weight loss, cardiovascular and renal protection in addition to adverse effects including genitourinary tract infections, ketoacidosis, and bone loss.
May E. Montasser, Salma A. Bargal, Elizabeth A. Streeten, Hilary B. Whitlatch, Zhinous Shahidzadeh Yazdi, Jordin Sirody, Rosanna Kiplagat, Merna Beshara, Jeffrey R. O’Connell, Simeon I. Taylor, Amber L. Beitelshees   +10 more
wiley   +1 more source

Atezolizumab-Associated Autoimmune Diabetes Presenting as Diabetic Ketoacidosis in a Woman With Hepatocellular Carcinoma: A Case Report. [PDF]

Cureus
Hayat I, Hayat S, Tahir T, Loo M.
europepmc   +1 more source

Policy gaps in type 1 diabetes: A UK audit of National Governing Bodies

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Aims National Governing Bodies (NGBs) for sport in the United Kingdom (UK) are responsible for setting standards and ensuring safe, inclusive participation for all, including people with type 1 diabetes (T1D). This audit systematically assessed the extent and quality of policy provision among UK‐based NGBs, focusing on support for athletes ...
Mohammed Abdel‐Magid, Emma J. Cockcroft, Chris Bright, Robert H. Mann, Richard Pulsford, Robert C. Andrews   +5 more
wiley   +1 more source

Acute Esophageal Mucosal Lesion Mimicking Severe Reflux Esophagitis in Diabetic Ketoacidosis: A Diagnostic Pitfall. [PDF]

Diagnostics (Basel)
Midori Y, Hayashi K, Hayashi M, Matsuda H.   +3 more
europepmc   +1 more source

Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed‐methods study

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Aims Research and policy initiatives for type 1 diabetes (T1D) across European countries demonstrate an emergent, critical shift towards universal paediatric screening. National adaptations of screening, however, remain under‐researched. The current study, as part of the EU‐funded EDENT1FI programme, aimed to examine the psychosocial impact ...
O. Boiko, K. Barnard‐Kelly, J. Vercauteren, S. M. Greenfield, R. P. Dias, L. M. Quinn, I. Litchfield, T. Papanikolaou, J. L. Dunne, G. Perego, F. Gatti, F. Milano, B. M. Milazzo, V. Di Mattei, K. Lange, C. Mathieu, L. Overbergh, A.‐G. Ziegler, C. Hurtado Del Pozo, M. G. Scarale, A. Mahieu, A. J. Omar Alsaleh, E. Bosi, P. Narendran, on behalf of the EDENT1FI Consortium, C. Mathieu, P. Gillard, K. Casteels, B. van der Schueren, L. Overbergh, J. Vercauteren, A. G. Ziegler, P. Achenbach, F. Haupt, C. Winkler, S. Hummel, F. Reschke, O. Kordonouri, T. von dem Berge, K. Lange, T. Pieber, J. Mader, S. Moitzi, S. Del Prato, B. Torbeyns, Z. Sumnik, O. Cinek, V. Neuman, B. Berka, F. Pociot, B. Petersen, J. Antvorskov, J. H. Klaebel, R. Lahesmaa, H. Hyöty, J. E. Laiho, F. Reschke, O. Kordonouri, T. von dem Berge, E. Bonifacio, R. Berner, A. Hommel, A. Loff, G. Gemulla, N. Zubizarreta, E. Bosi, L. Piemonti, V. Lampasona, F. Dotta, G. Sebastiani, A. Szypowska, K. Karczewski, P. Jarosz‐Chobot, J. F. Raposo, R. Ribeiro, R. Coelho, M. Peakman, E. Niemoeller, M. Baccara‐Dinet, J. Van Rampelbergh, R. Bergholdt, K. Fogh, O. Cohen, M. I. Buompensiere, C. Hurtado del Pozo, E. Latres, G. Agiostratidou, A. Koralova, J. Jackson, D. Darrock, H. Tewson, S. Nagallas, J. Hedrick, K. Collins, T. Tree, C. Dayan, K. Hood, J. Townson, R. Playle, R. Besser, P. Narendran, I. Litchfield, S. Greenfield, R. Dias   +103 more
wiley   +1 more source

Euglycemic Diabetic Ketoacidosis Treatment Protocol With Increased Dextrose Supplementation to Prevent Hypoglycemia. [PDF]

Acad Emerg Med
Clark AT, Sell J, Ang L, Esfandiari NH, Cranford JA, Haas NL.   +5 more
europepmc   +1 more source

Evaluation of a novel eating disorder prevention programme (Australian diabetes body project) for young women with type 1 diabetes in a clinic setting: A randomized controlled trial protocol

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Background Co‐occurrence of eating disorders (ED) and type 1 diabetes (T1D) can lead to deterioration in glycaemic control with reduced quality of life, microvascular complications, diabetic ketoacidosis and premature death. The current trial aims to test the effectiveness of an Australian Diabetes Body Project (ADBP) programme, a cognitive ...
Neisha D'Silva, Kerri M. Gillespie, Christel Hendrieckx, Line Wisting, Tatjana Ewais, Liza Phillips, Simon Denny, Selena Bartlett, Melanie White, Hannah Mackay, Margaret Vitanza, Isabella Magee, Alison Griffin, Lee Jones, Eric Stice   +14 more
wiley   +1 more source

Euthyroid Sick Syndrome as a Predictor of Hospital Stay in Pediatric Diabetic Ketoacidosis. [PDF]

J Clin Med
Alqahtani YA, A Shati A, Alshaikh AA, Alasmari AHN, Alghamdi FA, Alamri NA, Summan SI, Atif OMA, Ghazy RM.   +8 more
europepmc   +1 more source

‘Darkness as we face the unknown’: Biopsychosocial‐spiritual experiences of parents of children and young people with type 1 diabetes from the Middle East and North Africa (MENA) region

Diabetic Medicine, Volume 43, Issue 6, June 2026.
Abstract Aim Qualitative interviews were conducted as part of the development of a person‐reported outcome measure (PROM) to assess biopsychosocial‐spiritual outcomes of parents of children with type 1 diabetes (T1D) in the Middle East and North Africa (MENA) region.
Mariam Asaad, Haya Abu Ghazaleh, Vasiliki Tzouvara, Nada Aljohani, Shatha Alsayed, Jackie Sturt   +5 more
wiley   +1 more source